Carter's, Inc.
NYSE:CRIApparel - Retail
+$1.03 today
- Market cap
- $1.35B
- Beta
- 0.87
- P/E (TTM)
- 16.6
- EPS (TTM)
- $2.56
- Dividend yield
- 2.36%
Volume 1.93M
Average 1.05M
CRI Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Carter's, Inc.NYSE: CRI
Capital Expenditures · Q1 FY2026 · quarter ended Apr 2026
Capital expenditures declines year over year
Q1 FY2026 capital expenditures of $6.96M (cash outflow) fell 32.7% year over year, behind the -7.7% change in trailing-twelve-month capital expenditures. Sequentially, it fell 37.0% from the prior quarter. Over 3 fiscal years it compounded at +10.0% a year.
Context
- Capital expenditures amounted to 1.9% of revenue in FY2025, down 0.1 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -32.7% toward the trailing-twelve-month pace of -7.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (53.7M) USD
- Year-over-year change
- +4.4%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | (53.7M) | +4.4% |
| FY2024 | 2024-12-28 | (56.17M) | +6.2% |
| FY2023 | 2023-12-31 | (59.86M) | -48.3% |
| FY2022 | 2022-12-31 | (40.36M) | -7.8% |
| FY2021 | 2021-12-31 | (37.44M) | — |
Capital Expenditures vs competitors
How CRI compares with its peers on the latest reported figures
- CRI's LTM Apr 2026 capital expenditures of $50.32M is the 4th largest of the 9 companies compared; the peer median is $41.02M.
- Its year-over-year change of -7.7% is the 5th highest of 9, against a peer median of -6.7%.
- Capital expenditures amounts to 1.7% of revenue for CRI, versus a peer median of 4.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
HDLSUPER HI INTERNATIONAL HOLDING Ltd. American Depositary Shares | LTM Jun 2025 | $85.79M | +53.5% | -4.1% | 10.7% |
| LTM Mar 2026 | $68.2M | -1.2% | -17.1% | 1.7% | |
| LTM Dec 2024 | $57.34M | -43.2% | -15.9% | 6.2% | |
| LTM Apr 2026 | $50.32M | -7.7% | +10.0% | 1.7% | |
| LTM Mar 2026 | $46.45M | -40.1% | +11.5% | 3.0% | |
| LTM Apr 2026 | $35.58M | -3.6% | +17.7% | 1.2% | |
| LTM Mar 2026 | $30.02M | -9.8% | +0.7% | 7.5% | |
| LTM Jun 2026 | $5.59M | +62.4% | +33.6% | 0.3% | |
| LTM Mar 2026 | $3.89M | -28.6% | -35.3% | 13.9% | |
| Peer median (excluding CRI) | $41.02M | -6.7% | -1.7% | 4.6% | |
Competitors are the stored peer set for CRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 339.75M | 250.04M | 232.5M | 185.51M | 91.8M |
| Depreciation & Amortization | 94.11M | 65.28M | 64.14M | 57.93M | 55.26M |
| Deferred Income Tax | (13.53M) | (740K) | (600K) | (6.42M) | (162K) |
| Stock-Based Compensation | 21.03M | 21.88M | 19.46M | 17.84M | 20.25M |
| Change in Working Capital | (179.84M) | (287.78M) | 225.74M | 11.59M | (57.28M) |
| Accounts Receivables | (46.48M) | 32.68M | 15.45M | (13.74M) | 15.17M |
| Inventory | (52.91M) | (106.76M) | 222.92M | 26.13M | (37.1M) |
| Accounts Payables | (101.11M) | (228.6M) | (16.95M) | 2.16M | (27.25M) |
| Other Working Capital | 20.67M | 14.9M | 4.32M | (2.96M) | (8.1M) |
| Other Non-Cash Items | 6.74M | 39.69M | (12.11M) | 32.35M | 12.47M |
| Operating Cash Flow | 268.26M | 88.36M | 529.13M | 298.79M | 122.33M |
| Capital Expenditures | (37.44M) | (40.36M) | (59.86M) | (56.17M) | (53.7M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 5M | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (32.44M) | (40.36M) | (59.86M) | (56.17M) | (53.7M) |
| Debt Repayment | 0 | (380M) | (120M) | 0 | 63.29M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (299.34M) | (299.67M) | (100.03M) | (50.53M) | 0 |
| Dividends Paid | (60.12M) | (118.11M) | (112.01M) | (116.18M) | (56.36M) |
| Other Financing Activities | 6.75M | (21.49M) | (606K) | (8.11M) | (4.89M) |
| Financing Cash Flow | (352.71M) | (819.27M) | (332.65M) | (174.82M) | 2.04M |
| Effect of Forex Changes | (1.14M) | (1.27M) | 2.84M | (6.09M) | 3.48M |
| Net Change in Cash | (118.03M) | (772.55M) | 139.47M | 61.71M | 74.15M |
| Free Cash Flow | 230.82M | 48M | 469.27M | 242.62M | 68.63M |
Carter's, Inc.
NYSE:CRI
Intrinsic Alpha fair value
Locked
Current Price
$36.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.